CTRI/2020/02/023347尚未招募4 期
Pharmaceutico analytical and clinical study of Vanga Bhasma with phaltrikadi kwath W.S.R. to Madhumeha (D.M.)
Shubhdeep Ayurveda Medical College Hospital Indore0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Diabetes mellitus type 2 in Non-obese patients
- •2 Patients between the age group of 30-70 years with irrespective of gender
- •3 Patients willing to participate in the study period of 45 days
- •4 FBS more than 110 mg/dl and PPBS more than 140 mg/dl or both
- •5 BMI less than 25 kg/m2
排除标准
- •1 Diabetes mellitus type 2 in obese patients
- •2 Patients of IDDM
- •3 Patients age less than 30 years and more than 70 years
- •4 patients of gestational diabetes, juvenile diabetes , malignancy T.B gangrene and any other complications of diabetes
- •5 patients with an evidence of suffering from any severe systemic disease
- •6 FBS less than 110 mg/dl and PPBS less than 140 mg/dl
研究者
相似试验
已完成
1 期
PHARMACEUTICAL ANALYTICAL AND CLINICAL STUDY OF VANARI GUTIKA AND VANARI AVALEHA IN APHRODISIAC EFFECTCTRI/2018/07/015060ational Institute of Ayurveda Jaipur30
招募中
1 期
fracture treatmentCTRI/2018/04/012918Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
尚未招募
不适用
To evaluate the efficacy of lajjalu taila in uterine prolapseCTRI/2023/01/048677Shri BMK Ayurveda Mahavidyalaya
尚未招募
不适用
laghu -sut shekhar ras in the management of Ardhavbhedak W.S.R to MigraineCTRI/2021/12/038467Dr amit naageshwar
已完成
1 期
Study to find out if the drug Vessel Dilator” is absorbed from an infusion under the skin and is safe and tolerated and improves heart function in people diagnosed with stable congestive heart failure and a moderate degree of kidney function loss.ACTRN12612000576820Madeleine Pharmaceuticals Pty Ltd18